Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Comment by SpaceLabson Nov 20, 2021 8:51pm
254 Views
Post# 34150047

RE:Spacelab, the failed retail investor. Sell your SHARES!!!

RE:Spacelab, the failed retail investor. Sell your SHARES!!!You can GUESS anything, much appreciated AB42,,,, BUT the FACT REMAINS, i.e  XRX TANKING every DAY since NASDAQ LISTING and NOT in CONTROL of  a NO NAME ROADRUNNER FINANCIER in NY who NOT only walked away FOOLING Allen D'Doff with a 30% DISCOUNT.

1.  Lets figure: 1/12 RollBack= 120% on our Shoulders as Discount.
2.  30% to the RoadRunner in NY
3. 120% +  30% =  150% Discounted by CEO Allen who Raised a MERE SUM US$12 Million in IPO using DINGBAT/ BLINDBAT Financier in NY for Nasdaq.

You AB42 call this GREAT PERFORMANCE by Dr. CEO Allen???


Anklebiter42 wrote: You are probably excellent at collecting shopping carts at WALMART. BUT please STEP DOWN from owning XRTX shares. You are a FAILED Retail INVESTOR. 


<< Previous
Bullboard Posts
Next >>